Does CASODEX Cause Malignant neoplasm progression? 10 Reports in FDA Database
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 10 reports of Malignant neoplasm progression have been filed in association with CASODEX. This represents 17.5% of all adverse event reports for CASODEX.
10
Reports of Malignant neoplasm progression with CASODEX
17.5%
of all CASODEX reports
1
Deaths
3
Hospitalizations
How Dangerous Is Malignant neoplasm progression From CASODEX?
Of the 10 reports, 1 (10.0%) resulted in death, 3 (30.0%) required hospitalization, and 1 (10.0%) were considered life-threatening.
Is Malignant neoplasm progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for CASODEX. However, 10 reports have been filed with the FAERS database.
What Other Side Effects Does CASODEX Cause?
What Other Drugs Cause Malignant neoplasm progression?
PEMBROLIZUMAB (10,111)
NIVOLUMAB (9,363)
ENZALUTAMIDE (4,696)
CARBOPLATIN (4,177)
EVEROLIMUS (3,789)
PACLITAXEL (3,484)
LETROZOLE (3,445)
IPILIMUMAB (3,296)
FULVESTRANT (3,221)
LENVATINIB (2,929)